Clinical Trials Browser

Phase 1 × olverembatinib × 90 days × Clear all

NCT03594422 2026-04-09

A Study of HQP1351 in Patients With GIST or Other Solid Tumors

Phase 1 Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors